Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca Replies to FDA’s Decision on Brilinta
AstraZeneca Replies to FDA’s Decision on Brilinta
AstraZeneca Replies to FDA’s Decision on Brilinta
Submitted by
admin
on January 21, 2011 - 7:55am
Source:
Bloomberg
News Tags:
Brilinta
FDA
AstraZeneca
blood thinners
Headline:
AstraZeneca Replies to FDA’s Decision on Brilinta
Do Not Allow Advertisers to Use My Personal information
